Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Starting soon Observational

X-ray Assisted Diagnostic System

NCT07497243 · tracked via the Priya Life Science China tracker
Phase
Observational
Started
2026-05-01
Last updated
2026-03-27

Condition(s) studied

Chest X-ray for Clinical Evaluation

Investigational drug(s) / intervention(s)

AI-assisted radiologist diagnostic groupRadiologist diagnostic group

AI-assisted radiologist diagnostic group: Based on the previously developed X-ray image diagnosis and report generation model, radiologists are assisted in interpreting X-ray images and generating reports.

Radiologist diagnostic group: After the patient undergoes an X-ray examination, a radiologist generates the report and makes the diagnosis.

Study summary

X-ray examination is one of the most commonly used imaging modalities, especially chest X-ray, which is routinely performed for hospitalized patients. However, due to the low density resolution of X-ray images, radiologists' ability to diagnose diseases-particularly small lesions-is often affected. Studies have shown that the diagnostic accuracy of radiologists using chest X-rays is only around 70%, which does not meet clinical demands.

Based on this, we developed an artificial intelligence model to assist radiologists in interpreting X-ray images and generating reports, with the aim of improving diagnostic accuracy and reducing interpretation time.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Clinically suspected thoracic diseases (such as pneumonia, tuberculosis, or lung cancer) requiring X-ray diagnosis; * Patients providing written informed consent for research data use; * Complete clinical records (including chief complaints, medical history, and laboratory test results) Exclusion Criteria: * Substandard X-ray image quality (including severe motion artifacts, over-/underexposure, or missing anatomical structures) * Pregnant or lactating women

Primary outcome measure(s)

  • Area Under the Curve — From enrollment to the end of X-ray image acquisition at 1 week
    The primary outcome was the AUC to evaluate diagnostic performance, comparing radiologists with and without AI assistance.

Trial sites (4)

FacilityCityRegionStatus
Wuhan Union Hospital Wuhan Hubei
Wuhan Union Jinyin Lake Hospital Wuhan Hubei
Wuhan Union West Hospital Wuhan Hubei
The First Affiliated Hospital of Zhengzhou University Zhengzhou China
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07497243 on ClinicalTrials.gov ↗ ← All trials in China